Table 1 Characteristics of study population (n = 115).
Characteristic | No. (%) |
|---|---|
Male | 71 (62) |
Age, median (IQR), y | 76 (73–79) |
Diagnosis | |
- AML primary | 70 (61) |
- AML secondary | 24 (21) |
- MDS | 21 (18) |
ELN 2017 risk – for AML patients | |
- Favorable | 20 (17) |
- Intermediate | 16 (14) |
- Adverse | 58 (50) |
IPSS-R risk score – for MDS patients | |
≤ 6 | 16 (14) |
> 6 | 5 (4) |
